Muscular Dystrophies Market Set to Grow Further, Says Black Swan Analysis in New Report Published at MarketPublishers.com
30 Jan 2017 • by Natalie Aster
LONDON – Muscular dystrophies represent a group of over 30 genetic diseases that are characterized by progressive weakness o muscles and their degeneration resulting into the reduced mobility. When it comes to specific types of MD, they are classified according to the pattern of inheritance, severity, the age at onset, ad more.
Different organs and system can be hit by different types of MD: a heart, brain, muscles of respiration, etc.
Males are major victims of these diseases: the estimated incidence is around 1/3,300 male births. The female population, in the meantime, is asymptomatic. Still, some women experience milder forms of MD.
In the UK alone, there are over 70,000 people suffering from MD or related conditions. Duchenne MD represents the most common type of the disease. Myotonic MD forms the second most common type.
New research report “Muscular Dystrophies Forecast in 12 Major Markets 2017-2027” drawn up by Black Swan Analysis limited offers an up-close look at the world’s MD marketplace. The study starts with a detailed introduction to this market.
It discovers causes of the disease. The report explores risk factors and their prevention. The research study sheds light on the diagnosis of the disease.
It discusses the clinical course and the prognosis of the disease. The research report discloses key comorbid conditions as well as features that are associated with MD.
The study casts light on types of MD. It contains valuable pricing data and focuses on the patient-based offering. The report concentrates on twelve major markets. The research study also contains future projections for the period 2017-2027.
More new research reports by our partner are available at its page.